首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Systems Pharmacology Dissection of Traditional Chinese Medicine Wen-Dan Decoction for Treatment of Cardiovascular Diseases
【2h】

Systems Pharmacology Dissection of Traditional Chinese Medicine Wen-Dan Decoction for Treatment of Cardiovascular Diseases

机译:中药温丹汤治疗心血管疾病的系统药理学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiovascular diseases (CVDs) have been recognized as first killer of human health. The underlying mechanisms of CVDs are extremely complicated and not fully revealed, leading to a challenge for CVDs treatment in modern medicine. Traditional Chinese medicine (TCM) characterized by multiple compounds and targets has shown its marked effects on CVDs therapy. However, system-level understanding of the molecular mechanisms is still ambiguous. In this study, a system pharmacology approach was developed to reveal the underlying molecular mechanisms of a clinically effective herb formula (Wen-Dan Decoction) in treating CVDs. 127 potential active compounds and their corresponding 283 direct targets were identified in Wen-Dan Decoction. The networks among active compounds, targets, and diseases were built to reveal the pharmacological mechanisms of Wen-Dan Decoction. A “CVDs pathway” consisted of several regulatory modules participating in therapeutic effects of Wen-Dan Decoction in CVDs. All the data demonstrates that Wen-Dan Decoction has multiscale beneficial activity in CVDs treatment, which provides a new way for uncovering the molecular mechanisms and new evidence for clinical application of Wen-Dan Decoction in cardiovascular disease.
机译:心血管疾病(CVD)已被公认为是人类健康的第一杀手。 CVD的潜在机制极其复杂,尚未完全揭示,这给现代医学中的CVD治疗带来了挑战。具有多种化合物和靶标的中药(TCM)已显示出对CVDs治疗的显着效果。但是,对分子机理的系统级理解仍然是模棱两可的。在这项研究中,开发了一种系统药理学方法来揭示临床有效的草药配方(文丹汤)在治疗CVD中的潜在分子机制。在文旦汤中鉴定出127种潜在的活性化合物及其相应的283种直接目标。建立了活性化合物,靶标和疾病之间的网络,以揭示文丹汤的药理机制。 “ CVD途径”由参与文旦汤对CVD的治疗作用的几个调节模块组成。所有数据表明,文旦汤在心血管疾病治疗中具有多方面的有益活性,为揭示文丹汤在心血管疾病中的分子机制和临床应用提供了新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号